Semler Scientific, Inc. (SMLR)

23,35 -0,19 (-0,81%) Alla chiusura: 04:00PM EDT

Semler Scientific, Inc.

2340-2348 Walsh Avenue
Suite 2344
Santa Clara, CA 95051
United States
(877) 774-4211
https://www.semlerscientific.com

Settore/i: Healthcare
Settore: Medical Devices
Impiegati a tempo pieno: 92

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Dr. Douglas Murphy-Chutorian M.D.	CEO, President & Director	963,58k	N/D	1954
Ms. Renae Cormier	CFO, Principal Accounting Officer, Head of Corp. Communications & Bus. Strategy and Secretary	374,71k	N/D	1973
Dr. Herbert J. Semler	Founder & Chairman Emeritus	41,25k	N/D	1928
Ms. Jennifer Oliva Herrington	Chief Operating Officer	N/D	N/D	N/D
Mr. Shane Reid	Chief Technology Officer	N/D	N/D	N/D
Ms. Cindy Guinasso	Senior Vice President of Business Development	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.

Governance aziendale

L'ISS Governance QualityScore di Semler Scientific, Inc. al 1 maggio 2024 è 7. I criteri di valutazione fondamentali sono revisione: 5; Consiglio di Amministrazione: 8; diritti degli azionisti: 7; retribuzione: 6.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.